Differentiating solitary pulmonary metastases in patients with renal cell carcinomas by 18F-fluoro-2-deoxyglucose positron emission tomography - A preliminary report

Urologia Internationalis

Volumn 71, Issue 3, 2003, Pages 306-309

  Chang, Chao Hsiang ^a   Shiau, Yu Chien ^b   Shen, Yeh You ^c   Kao, Albert ^a   Lin, Cheng Chieh ^a   Lee, Cheng Chun ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

18F Fluoro 2 deoxyglucose; Positron emission tomography; Renal cell carcinoma; Solitary pulmonary metastases

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADULT; AGED; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0141649403     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072683     Document Type: Article

References (16)

1. Cozzoli A, Milano S, Cancarini G, Zanotelli T, Cunico SC: Surgery of lung metastases in renal cell carcinoma. Br J Urol 1995;75:445-447.
2. Swoboda L, Toomes H: Results of surgical treatment for pulmonary metastases. Thorac Cardiovasc Surg 1986;34:2149-2152.
3. Hubner KF, Buonocore E, Singh SK, Gould HR, Cotton DW: Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med 1995;20:293-298.
4. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG: Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995;110:130-140.
5. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ: PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest 1995;108:441-446.
6. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, McNeil BJ: CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-713.
7. Halter G, Storck, Guhlmann A, Frank J, Grosse S, Liewald F: FDG positron emission tomography in diagnosis of peripheral pulmonary focal lesions. Thorac Cardiovasc Surg 2000;48:97-101.
8. Ber GM, Gupta NC, Murray GF: Positron emission tomography imaging with fluorodeoxy-glucose is efficacious in evaluating malignant pulmonary disease. J Thorac Cardiovasc Surg 1999;117:719-727.
9. Prauer HW, Weber WA, Romer W, Treumann T, Ziegler SI, Schwaiger M: Controlled prospective study of positron emission tomography using the glucose analogue [18F] fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg 1998;85:1506-1511.
10. Gupta NC, Maloof J, Gunel E: Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943-948.
11. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME: A tabulated summary of the FDG-PET literature. J Nucl Med 2001;42:1S-93S.
12. Strauss LG: Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415.
13. Knight SB, Delbeke D, Stewart JR, Sandler MP: Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996;109:982-988.
14. Lowe VJ, Duhaylongsod FG, Patz EF, Delong DM, Hoffman JM, Wolfe WG, Coleman RE: Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997;202:435-439.
15. Erasmus JJ, McAdms HP, Patz EF, Coleman RE, Ahuma V, Goodman PC: Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18F-fluorodeoxyglucose. AJR 1998;170:1369-1373.
16. Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, Taniguchi M, Tonami H, Okimura T, Yamamoto I: Fluorine-18-FDG PET imaging is negative in bronchioalveolar lung carcinoma. J Nucl Med 1998;39:1016-1020.